Global Cord Blood (NYSE:CO) Shares Pass Above 200-Day Moving Average - What's Next?

Key Points

• Global Cord Blood shares have crossed above their 200-day moving average, indicating potential upward momentum in the stock price.
• The company's market capitalization stands at $121.55 million with a low PE ratio of 1.56, suggesting it may be undervalued.
• Global Cord Blood specializes in cord blood banking services, including processing, storage, and provision of matching services for stem cell transplants.

Shares of Global Cord Blood Co. (NYSE:CO - ) passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $1.00 and traded as high as $1.00. Global Cord Blood shares last traded at $1.00, with a volume of 0 shares traded.

Global Cord Blood Stock Performance

The company has a market cap of $121.55 million, a PE ratio of 1.56 and a beta of 0.16. The stock has a 50 day moving average of $1.00 and a 200-day moving average of $1.00.

Global Cord Blood Company Profile

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.